Confirmed my suspicions that there would be significant shortfall and underwriters would be trying to do a P&D to get their money back. Just be careful not to fall for that trick.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025